Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China and Key Laboratory of Biomedical Informatics and Health Engineering, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Shenzhen 518055, China.
Biomicrofluidics. 2010 Oct 8;4(4):44104. doi: 10.1063/1.3497376.
In vitro sensitivity testing of tumor cells could rationalize and improve the choice of chemotherapy and hormone therapy. In this report, a microfluidic device made from poly(dimethylsiloxane) and glass was developed for an assay of drug induced cytotoxicity. We evaluated the apoptotic and proliferation-inhibitory effects of anticancer drugs mitomycin C (MMC) and tamoxifen (TAM) using MCF-7 breast cancer cells. MMC and TAM both induced apoptosis and inhibited proliferation of MCF-7 cells in a concentration-dependent manner. MMC caused the expression of antiapoptotic protein Bcl-2 a dose-dependent reduction in MCF-7 cells. The expression of Bcl-2 did not change significantly in MCF-7 cells treated by TAM. The results in the microfluidic device were correlated well with the data obtained from the parallel experiments carried out in the conventional culture plates. The developed microfluidic device could be a potential useful tool for high content screening and high throughput screening research.
肿瘤细胞的体外药敏试验可以合理地选择化疗和激素治疗。在本报告中,我们开发了一种由聚二甲基硅氧烷和玻璃制成的微流控装置,用于测定药物诱导的细胞毒性。我们用 MCF-7 乳腺癌细胞评估了抗癌药物丝裂霉素 C(MMC)和他莫昔芬(TAM)的凋亡和增殖抑制作用。MMC 和 TAM 均以浓度依赖的方式诱导 MCF-7 细胞凋亡和增殖抑制。MMC 导致 MCF-7 细胞中抗凋亡蛋白 Bcl-2 的表达呈剂量依赖性降低。TAM 处理的 MCF-7 细胞中 Bcl-2 的表达没有明显变化。微流控装置中的结果与在常规培养板中进行的平行实验获得的数据相关性良好。开发的微流控装置可能成为高通量筛选和高通量筛选研究的一种有前途的有用工具。